Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.66	21.39	16.31	14.41	21.3	12.07
Cash & Cash Equivalents	16.66	21.39	16.31	14.41	21.3	12.07
Cash Growth	13.24%	31.17%	13.18%	-32.35%	76.49%	-54.87%
Receivables	4.24	3.41	1.85	5.47	0.05	0.47
Inventory	2.32	0.91	0.56	0.55	1.24	0.38
Other Current Assets	1.05	1.13	1.29	3.18	2.12	2.09
Total Current Assets	24.26	26.84	20	23.6	24.7	15.01
Property, Plant & Equipment	0.13	0.15	0.26	0.22	1	1.28
Goodwill and Intangibles	6.39	4.74	4.75	3.62	0.58	0.73
Other Long-Term Assets	0.01	0.01	0.01	0.02	0.04	0.06
Total Long-Term Assets	6.53	4.9	5.03	3.86	1.62	2.06
Total Assets	30.79	31.74	25.03	27.47	26.32	17.07
Accounts Payable	2.26	1.85	1.77	1.77	2.34	0.58
Current Debt	5.02	5.38	1.03	1.42	0.28	0
Other Current Liabilities	8.02	9.01	3.66	1.37	1.17	1.39
Total Current Liabilities	15.3	16.24	6.46	4.56	3.79	1.96
Long-Term Debt	0	0.02	5.49	5.28	6.86	4.56
Total Long-Term Liabilities	0	0.02	5.49	5.28	6.86	4.56
Total Liabilities	15.3	16.26	11.95	9.84	10.66	6.52
Total Debt	5.02	5.4	6.52	6.7	7.14	4.56
Debt Growth	-23.15%	-17.20%	-2.55%	-6.26%	56.66%	-
Retained Earnings	-104.88	-104.07	-103.13	-94.11	-92.16	-64.19
Shareholders' Equity	15.49	15.48	13.08	17.63	15.66	10.55
Net Cash / Debt	11.64	15.99	9.78	7.71	14.15	7.51
Net Cash / Debt Growth	42.31%	63.44%	26.84%	-45.52%	88.53%	-71.92%
Net Cash Per Share	0.45	0.62	0.39	0.31	0.67	0.42
Working Capital	8.96	10.6	13.54	19.05	20.91	13.05
Book Value Per Share	0.60	0.60	0.52	0.70	0.75	0.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).